|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/18 | |
| A61K 47/50 | |||
| A61K 47/69 | |||
| A61P 3/06 |
| (11) | Patento numeris | 3125921 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15710087.6 |
| Europos patento paraiškos padavimo data | 2015-03-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/019362 |
| Data | 2015-03-09 |
| (87) | Numeris | WO 2015/138278 |
| Data | 2015-09-17 |
| (30) | Numeris | Data | Šalis |
| 201461950960 P | 2014-03-11 | US |
| (72) |
DIENER, John Louis, US
GAO, Jiaping, US
SCHIEBINGER, Rick Jerome, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | FGF21 VARIANTS FOR USE IN TREATING HIV-HAART INDUCED PARTIAL LIPODYSTROPHY |
| FGF21 VARIANTS FOR USE IN TREATING HIV-HAART INDUCED PARTIAL LIPODYSTROPHY |